United States · FDA National Drug Code directory
Tizanidine HCL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80425-0144_43cfb518-01fc-0ea4-e063-6394a90a06d3
- Product NDC
- 80425-0144
- Form
- CAPSULE
- Composition / generic term
- Tizanidine HCL
- Labeler
- Advanced Rx Pharmacy of Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190329
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (80425-0144-1) · 80425-0144-1
- 60 CAPSULE in 1 BOTTLE (80425-0144-2) · 80425-0144-2
- 90 CAPSULE in 1 BOTTLE (80425-0144-3) · 80425-0144-3
- 120 CAPSULE in 1 BOTTLE (80425-0144-4) · 80425-0144-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →